Peptides are mid-size molecules composed of amino acids and constitute some of nature's best drugs. Designing these mid-size molecules computationally remains a challenge due to the astronomical search space and complex energy dynamics. Here, we explore how quantum annealing and hybrid approaches may offer a new alternative toolkit for designing peptide therapeutics that could hold the key to groundbreaking new drugs.